Biotech Company Connect Biopharma Raises US$115M in Series C
Connect Biopharma’s total capital pool nears the US$200 million mark U.S.- and China-based clinical-stage biopharmaceutical company Connect Biopharma has completed a fundraise of US$115 million in a Series C round, the company announced in a statement yesterday. The round was led by U.S.-based multi-stage investment manager RA Capital Management, the statement said. Principal at RA […]
Biotech Company Connect Biopharma Raises US$115M in Series C Read More »
Connect Biopharma’s total capital pool nears the US$200 million mark U.S.- and China-based clinical-stage biopharmaceutical company Connect Biopharma has completed a fundraise of US$115 million in a Series C round, the company announced in a statement yesterday. The round was led by U.S.-based multi-stage investment manager RA Capital Management, the statement said. Principal at RA
